These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25521938)

  • 1. STING, nanoparticles, autoimmune disease and cancer: a novel paradigm for immunotherapy?
    Lemos H; Huang L; McGaha T; Mellor AL
    Expert Rev Clin Immunol; 2015 Jan; 11(1):155-65. PubMed ID: 25521938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA.
    Lemos H; Huang L; McGaha TL; Mellor AL
    Eur J Immunol; 2014 Oct; 44(10):2847-53. PubMed ID: 25143264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the STING adaptor attenuates experimental autoimmune encephalitis.
    Lemos H; Huang L; Chandler PR; Mohamed E; Souza GR; Li L; Pacholczyk G; Barber GN; Hayakawa Y; Munn DH; Mellor AL
    J Immunol; 2014 Jun; 192(12):5571-8. PubMed ID: 24799564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for stimulator of interferon genes-targeted cancer immunotherapy.
    Rivera Vargas T; Benoit-Lizon I; Apetoh L
    Eur J Cancer; 2017 Apr; 75():86-97. PubMed ID: 28219022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Innate immune DNA sensing pathways].
    Abe T
    Uirusu; 2014; 64(1):83-94. PubMed ID: 25765984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expanding regulatory network of STING-mediated signaling.
    Surpris G; Poltorak A
    Curr Opin Microbiol; 2016 Aug; 32():144-150. PubMed ID: 27414485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STING-mediated DNA sensing in cancer immunotherapy.
    Zhou X; Jiang Z
    Sci China Life Sci; 2017 Jun; 60(6):563-574. PubMed ID: 28639100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon regulatory factors: A key to tumour immunity.
    Chen YJ; Li J; Lu N; Shen XZ
    Int Immunopharmacol; 2017 Aug; 49():1-5. PubMed ID: 28531759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging roles of the STING adaptor protein in immunity and diseases.
    Liu X; Wang C
    Immunology; 2016 Mar; 147(3):285-91. PubMed ID: 26643733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of immunoglobulin receptors and the effects on clinical outcome in cancer immunotherapy and other immune diseases: a general review.
    Kaifu T; Nakamura A
    Int Immunol; 2017 Jul; 29(7):319-325. PubMed ID: 28910969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine in autoimmunity.
    Clemente-Casares X; Santamaria P
    Immunol Lett; 2014; 158(1-2):167-74. PubMed ID: 24406504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-based autoimmune disease therapy.
    Serra P; Santamaria P
    Clin Immunol; 2015 Sep; 160(1):3-13. PubMed ID: 25704658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The STING pathway and the T cell-inflamed tumor microenvironment.
    Woo SR; Corrales L; Gajewski TF
    Trends Immunol; 2015 Apr; 36(4):250-6. PubMed ID: 25758021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of effective immunotherapy for human autoimmunity.
    Feldmann M; Steinman L
    Nature; 2005 Jun; 435(7042):612-9. PubMed ID: 15931214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-DNA, STING-dependent signaling and the origins of autoinflammatory disease.
    Ahn J; Barber GN
    Curr Opin Immunol; 2014 Dec; 31():121-6. PubMed ID: 25459004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4th Australasian vaccines and immunotherapeutic development meeting.
    Engwerda C; Belz G
    Immunol Cell Biol; 2012 Nov; 90(10):921-4. PubMed ID: 23190698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional STING-Activating Mn
    Zhou M; Wang X; Lin S; Cheng Y; Zhao S; Lin J; Fang Z; Lou Z; Qin L; Wei H
    Adv Healthc Mater; 2020 Jul; 9(13):e2000064. PubMed ID: 32484320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Vaccine and Immunotherapy Design Using Biomaterials.
    Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
    Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy.
    Muenst S; Soysal SD; Tzankov A; Hoeller S
    Expert Opin Ther Targets; 2015 Feb; 19(2):201-11. PubMed ID: 25491730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.